HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 84 | 96 | 87.5% | |
| HF004 | 2020 | 84 | 97 | 86.6% | |
| HF006 | 2021 | 95 | 110 | 86.4% | |
| HF006 | 2022 | 86 | 103 | 83.5% | |
| HF006 | 2023 | 104 | 109 | 95.4% | |
| HF006 | 2023 | 104 | 109 | 95.4% |
